VDAC1 and glioblastoma: Using human-specific small interfering-hVDAC1 (si-hVDAC1) to silence the expression of VDAC1 reduces cellular ATP levels and cell growth,10 and inhibits tumor growth in lung cancer9 and glioblastoma multiforme (GBM).11